{"SPADE_UN_16282": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16282", "Peptide Name": "Gradient2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "AWLKRIKKFLKALFWVWVW", "Sequence Length": 19, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (EC50=19.0 ± 1.8 µM); A549 (EC50>50 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C132H192N30O20", "Mass": 2519.13, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": 0.52, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "KWL", "Absent Amino Acids": "CDEGHMNOPQSTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_25165", "Similarity": 1.0, "Sequence": "WVVWVWRRR"}, {"SPADE_ID": "SPADE_N_09169", "Similarity": 0.75, "Sequence": "LKRIKTLL"}, {"SPADE_ID": "SPADE_N_10974", "Similarity": 0.75, "Sequence": "GLKRIKKL"}]}}}